Evidence map›Paper›PMID 30689363›Full record

ArticleACS nano2019

Customizing Morphology, Size, and Response Kinetics of Matrix Metalloproteinase-Responsive Nanostructures by Systematic Peptide Design.

Jiye Son, Daniela Kalafatovic, Mohit Kumar, Barney Yoo, Mike A Cornejo, María Contel, Rein V Ulijn

Abstract read
In one paragraph

Article in ACS nano, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Review
  3. Light-Triggered Disassembly of Peptide Nanostructures.Chembiochem : a European journal of chemical biology · 2025
    Article
  4. Review
  5. Review
  6. Review
  7. ACS biomaterials science & engineering · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. Self-Assembling Peptide-Based Hydrogels for Wound Tissue Repair.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. Modular Design of Supramolecular Ionic Peptides with Cell-Selective Membrane Activity.Chembiochem : a European journal of chemical biology · 2021
    Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jiye SonAdvanced Science Research Center at The Graduate Center of the City University of New York , 85 Saint Nicholas Terrace , New York , New York 10031 , United States.ORCID 0000-0003-3482-9813
Daniela KalafatovicAdvanced Science Research Center at The Graduate Center of the City University of New York , 85 Saint Nicholas Terrace , New York , New York 10031 , United States.
Mohit KumarAdvanced Science Research Center at The Graduate Center of the City University of New York , 85 Saint Nicholas Terrace , New York , New York 10031 , United States.
Barney YooDepartment of Chemistry , Hunter College , City University of New York, 695 Park Avenue , New York , New York 10065 , United States.
Mike A CornejoDepartment of Chemistry , Brooklyn College , City University of New York, 2900 Bedford Avenue , Brooklyn , New York 11210 , United States.
María ContelDepartment of Chemistry , Brooklyn College , City University of New York, 2900 Bedford Avenue , Brooklyn , New York 11210 , United States.ORCID 0000-0002-9825-4441
Rein V UlijnAdvanced Science Research Center at The Graduate Center of the City University of New York , 85 Saint Nicholas Terrace , New York , New York 10031 , United States.ORCID 0000-0002-7138-1213

Funding

Biodegradable nanocarriers and antibodies as targeting delivery vehicles for cancer metallodrugsSC1GM127278 · NIGMS · BROOKLYN COLLEGE · PI CONTEL, MARIA · 2018 to 2021
$1.6M
Titanium-gold-based chemotherapeutics for prostate and kidney cancerSC1CA182844 · NCI · BROOKLYN COLLEGE · PI CONTEL, MARIA · 2013 to 2016
$1.4M
NCI NIH HHS SC1 CA182844NIGMS NIH HHS SC1 GM127278
6 · The paper itself

Abstract

Overexpression and activation of matrix metalloproteinase-9 (MMP-9) is associated with multiple diseases and can serve as a stimulus to activate nanomaterials for sensing and controlled release. In order to achieve autonomous therapeutics with improved space-time targeting capabilities, several features need to be considered beyond the introduction of an enzyme-cleavable linker into a nanostructure. We introduce guiding principles for a customizable platform using supramolecular peptide nanostructures with three modular components to achieve tunable kinetics and morphology changes upon MMP-9 exposure. This approach enables (1) fine-tuning of kinetics through introduction of ordered/disordered structures, (2) a 12-fold variation in hydrolysis rates achieved by electrostatic (mis)matching of particle and enzyme charge, and (3) selection of enzymatic reaction products that are either cell-killing nanofibers or disintegrate. These guiding principles, which can be rationalized and involve exchange of just a few amino acids, enable systematic customization of enzyme-responsive peptide nanostructures for general use in performance optimization of enzyme-responsive materials.

Indexed as

KineticsMatrix Metalloproteinase 9Matrix MetalloproteinasesNanostructuresPeptidesMatrix Metalloproteinase 9Matrix MetalloproteinasesPeptideselectrostatic enzyme interactionsenzyme kineticsMMP-responsivemorphology changeself-assembling peptidessupramolecular organization

Identifiers

PMID30689363
PMCPMC6475088

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.